Literature DB >> 1161329

Intraluminal and intravenous 5-FU chemotherapy adjuvant to surgery for resectable colorectal cancer. A clinical cooperative multihospital project.

C E Grossi, W I Wolff, T F Nealson, B Pasternack, L Ginzburg, L M Rousselot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1161329

Source DB:  PubMed          Journal:  Panminerva Med        ISSN： 0031-0808            Impact factor:   5.197


× No keyword cloud information.
  2 in total

1.  Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).

Authors:  Rong-Xin Zhang; Jun-Zhong Lin; Jian Lei; Gong Chen; Li-Ren Li; Zhen-Hai Lu; Pei-Rong Ding; Jiong-Qiang Huang; Ling-Heng Kong; Fu-Long Wang; Cong Li; Wu Jiang; Chuan-Feng Ke; Wen-Hao Zhou; Wen-Hua Fan; Qing Liu; De-Sen Wan; Xiao-Jun Wu; Zhi-Zhong Pan
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

2.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.